Fahr's syndrome

Fahr's Syndrome
[[File:|250px|]]
Synonyms	Idiopathic Basal Ganglia Calcification
Pronounce	N/A
Specialty	N/A
Symptoms	Movement disorders, cognitive impairment, psychiatric symptoms
Complications	N/A
Onset	Typically in adulthood
Duration	N/A
Types	N/A
Causes	Genetic mutations, idiopathic
Risks	N/A
Diagnosis	CT scan, MRI
Differential diagnosis	N/A
Prevention	N/A
Treatment	Symptomatic
Medication	N/A
Prognosis	Variable
Frequency	N/A
Deaths	N/A

Fahr's Syndrome, also known as Idiopathic Basal Ganglia Calcification, is a rare, genetically heterogeneous neurological disorder characterized by abnormal calcification of the basal ganglia and other brain regions. This condition can lead to a variety of neurological and psychiatric symptoms.

Pathophysiology

The hallmark of Fahr's Syndrome is the presence of bilateral calcifications in the basal ganglia, thalamus, cerebellum, and other brain regions. These calcifications are primarily composed of calcium phosphate and are thought to result from disruptions in calcium metabolism. The exact pathophysiological mechanisms remain unclear, but genetic mutations have been implicated in some familial cases.

Genetics

Fahr's Syndrome can be inherited in an autosomal dominant, autosomal recessive, or sporadic manner. Several genes have been associated with the condition, including SLC20A2, PDGFB, and PDGFRB. Mutations in these genes can disrupt phosphate transport and vascular integrity, leading to abnormal calcium deposition.

Clinical Presentation

Patients with Fahr's Syndrome may present with a variety of symptoms, which can include:

• Movement disorders such as parkinsonism, chorea, and dystonia.
• Cognitive impairment, ranging from mild cognitive deficits to dementia.
• Psychiatric symptoms, including depression, psychosis, and anxiety.
• Seizures and other neurological deficits.

The age of onset and severity of symptoms can vary widely among individuals.

Diagnosis

The diagnosis of Fahr's Syndrome is primarily based on neuroimaging findings. A CT scan is the most sensitive method for detecting brain calcifications, which appear as hyperdense areas in the basal ganglia and other regions. MRI can also be used to assess the extent of calcification and associated brain changes.

Genetic testing may be performed to identify mutations in known associated genes, particularly in familial cases.

Management

There is no cure for Fahr's Syndrome, and treatment is primarily symptomatic. Management strategies may include:

• Medications to control movement disorders, such as levodopa for parkinsonism.
• Antipsychotic or antidepressant medications for psychiatric symptoms.
• Antiepileptic drugs for seizure control.

Regular follow-up with a neurologist is recommended to monitor disease progression and adjust treatment as needed.

Prognosis

The prognosis of Fahr's Syndrome is variable and depends on the severity and progression of symptoms. Some individuals may experience a stable course with mild symptoms, while others may have progressive neurological decline.

Also see

• Basal ganglia
• Calcium metabolism
• Neurodegenerative disorders
• Genetic testing

edit 

WikiMD neurology

External links

• Comprehensive information from the National Institute of health.
  

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z